Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions

Richard Malley, Louis Vernacchio, John Devincenzo, Octavio Ramilo, Penelope H. Dennehy, H. Cody Meissner, William C. Gruber, Hasan S. Jafri, Pablo J. Sanchez, Kristin Macdonald, John B. Montana, Claudette M. Thompson, Donna M. Ambrosino

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective. We developed an enzyme-linked immunosorbent assay (ELISA) for the quantitation of respiratory syncytial virus (RSV) in respiratory secretions in intubated patients infected with RSV. Methods. We compared the quantitative ELISA and a standardized plaque assay in intubated children <2 years of age who were mechanically ventilated for severe RSV disease and enrolled in a randomized double blind placebo-controlled treatment trial of a monoclonal antibody to the F protein of RSV (palivizumab; Synagis). We also examined the relationship between the concentrations of virus as measured by ELISA and of three inflammatory indices in respiratory secretions (white blood cell count, myeloperoxidase and eosinophilic cationic protein). Results. Quantitative ELISA and plaque assay were highly correlated for both tracheal aspirates (r = 0.67, P = 0.001) and nasal wash specimens (r = 0.75, P = 0.001). Treatment with palivizumab significantly neutralized RSV in tracheal aspirates as measured by plaque assay. In contrast quantitation of RSV by ELISA was not affected by palivizumab treatment. This finding is consistent with results that were obtained in preliminary studies of RSV- containing media treated with monoclonal antibody, where we found that the ELISA measured virus whether antibody-bound or not. The inflammatory indices were not correlated with RSV concentration measured by ELISA or plaque assay. Conclusions. We conclude that this quantitative ELISA is a potentially useful tool for measurement of RSV concentration in respiratory secretions that may help elucidate the pathophysiology of acute RSV infection. Specific antiviral strategies for the treatment of RSV disease could be evaluated by this method.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalPediatric Infectious Disease Journal
Volume19
Issue number1
StatePublished - Jan 2000

Fingerprint

Respiratory Syncytial Viruses
Enzyme-Linked Immunosorbent Assay
Virus Diseases
Monoclonal Antibodies
Viruses
Respiratory Syncytial Virus Infections
Therapeutics
Leukocyte Count
Nose
Peroxidase
Antiviral Agents
Proteins
Placebos

Keywords

  • Enzyme-linked immunosorbent assay
  • Respiratory syncytial virus
  • Tracheal secretions

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)

Cite this

Malley, R., Vernacchio, L., Devincenzo, J., Ramilo, O., Dennehy, P. H., Meissner, H. C., ... Ambrosino, D. M. (2000). Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions. Pediatric Infectious Disease Journal, 19(1), 1-7.

Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions. / Malley, Richard; Vernacchio, Louis; Devincenzo, John; Ramilo, Octavio; Dennehy, Penelope H.; Meissner, H. Cody; Gruber, William C.; Jafri, Hasan S.; Sanchez, Pablo J.; Macdonald, Kristin; Montana, John B.; Thompson, Claudette M.; Ambrosino, Donna M.

In: Pediatric Infectious Disease Journal, Vol. 19, No. 1, 01.2000, p. 1-7.

Research output: Contribution to journalArticle

Malley, R, Vernacchio, L, Devincenzo, J, Ramilo, O, Dennehy, PH, Meissner, HC, Gruber, WC, Jafri, HS, Sanchez, PJ, Macdonald, K, Montana, JB, Thompson, CM & Ambrosino, DM 2000, 'Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions', Pediatric Infectious Disease Journal, vol. 19, no. 1, pp. 1-7.
Malley, Richard ; Vernacchio, Louis ; Devincenzo, John ; Ramilo, Octavio ; Dennehy, Penelope H. ; Meissner, H. Cody ; Gruber, William C. ; Jafri, Hasan S. ; Sanchez, Pablo J. ; Macdonald, Kristin ; Montana, John B. ; Thompson, Claudette M. ; Ambrosino, Donna M. / Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions. In: Pediatric Infectious Disease Journal. 2000 ; Vol. 19, No. 1. pp. 1-7.
@article{97234955a750420790912fdf481b073e,
title = "Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions",
abstract = "Objective. We developed an enzyme-linked immunosorbent assay (ELISA) for the quantitation of respiratory syncytial virus (RSV) in respiratory secretions in intubated patients infected with RSV. Methods. We compared the quantitative ELISA and a standardized plaque assay in intubated children <2 years of age who were mechanically ventilated for severe RSV disease and enrolled in a randomized double blind placebo-controlled treatment trial of a monoclonal antibody to the F protein of RSV (palivizumab; Synagis). We also examined the relationship between the concentrations of virus as measured by ELISA and of three inflammatory indices in respiratory secretions (white blood cell count, myeloperoxidase and eosinophilic cationic protein). Results. Quantitative ELISA and plaque assay were highly correlated for both tracheal aspirates (r = 0.67, P = 0.001) and nasal wash specimens (r = 0.75, P = 0.001). Treatment with palivizumab significantly neutralized RSV in tracheal aspirates as measured by plaque assay. In contrast quantitation of RSV by ELISA was not affected by palivizumab treatment. This finding is consistent with results that were obtained in preliminary studies of RSV- containing media treated with monoclonal antibody, where we found that the ELISA measured virus whether antibody-bound or not. The inflammatory indices were not correlated with RSV concentration measured by ELISA or plaque assay. Conclusions. We conclude that this quantitative ELISA is a potentially useful tool for measurement of RSV concentration in respiratory secretions that may help elucidate the pathophysiology of acute RSV infection. Specific antiviral strategies for the treatment of RSV disease could be evaluated by this method.",
keywords = "Enzyme-linked immunosorbent assay, Respiratory syncytial virus, Tracheal secretions",
author = "Richard Malley and Louis Vernacchio and John Devincenzo and Octavio Ramilo and Dennehy, {Penelope H.} and Meissner, {H. Cody} and Gruber, {William C.} and Jafri, {Hasan S.} and Sanchez, {Pablo J.} and Kristin Macdonald and Montana, {John B.} and Thompson, {Claudette M.} and Ambrosino, {Donna M.}",
year = "2000",
month = "1",
language = "English (US)",
volume = "19",
pages = "1--7",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions

AU - Malley, Richard

AU - Vernacchio, Louis

AU - Devincenzo, John

AU - Ramilo, Octavio

AU - Dennehy, Penelope H.

AU - Meissner, H. Cody

AU - Gruber, William C.

AU - Jafri, Hasan S.

AU - Sanchez, Pablo J.

AU - Macdonald, Kristin

AU - Montana, John B.

AU - Thompson, Claudette M.

AU - Ambrosino, Donna M.

PY - 2000/1

Y1 - 2000/1

N2 - Objective. We developed an enzyme-linked immunosorbent assay (ELISA) for the quantitation of respiratory syncytial virus (RSV) in respiratory secretions in intubated patients infected with RSV. Methods. We compared the quantitative ELISA and a standardized plaque assay in intubated children <2 years of age who were mechanically ventilated for severe RSV disease and enrolled in a randomized double blind placebo-controlled treatment trial of a monoclonal antibody to the F protein of RSV (palivizumab; Synagis). We also examined the relationship between the concentrations of virus as measured by ELISA and of three inflammatory indices in respiratory secretions (white blood cell count, myeloperoxidase and eosinophilic cationic protein). Results. Quantitative ELISA and plaque assay were highly correlated for both tracheal aspirates (r = 0.67, P = 0.001) and nasal wash specimens (r = 0.75, P = 0.001). Treatment with palivizumab significantly neutralized RSV in tracheal aspirates as measured by plaque assay. In contrast quantitation of RSV by ELISA was not affected by palivizumab treatment. This finding is consistent with results that were obtained in preliminary studies of RSV- containing media treated with monoclonal antibody, where we found that the ELISA measured virus whether antibody-bound or not. The inflammatory indices were not correlated with RSV concentration measured by ELISA or plaque assay. Conclusions. We conclude that this quantitative ELISA is a potentially useful tool for measurement of RSV concentration in respiratory secretions that may help elucidate the pathophysiology of acute RSV infection. Specific antiviral strategies for the treatment of RSV disease could be evaluated by this method.

AB - Objective. We developed an enzyme-linked immunosorbent assay (ELISA) for the quantitation of respiratory syncytial virus (RSV) in respiratory secretions in intubated patients infected with RSV. Methods. We compared the quantitative ELISA and a standardized plaque assay in intubated children <2 years of age who were mechanically ventilated for severe RSV disease and enrolled in a randomized double blind placebo-controlled treatment trial of a monoclonal antibody to the F protein of RSV (palivizumab; Synagis). We also examined the relationship between the concentrations of virus as measured by ELISA and of three inflammatory indices in respiratory secretions (white blood cell count, myeloperoxidase and eosinophilic cationic protein). Results. Quantitative ELISA and plaque assay were highly correlated for both tracheal aspirates (r = 0.67, P = 0.001) and nasal wash specimens (r = 0.75, P = 0.001). Treatment with palivizumab significantly neutralized RSV in tracheal aspirates as measured by plaque assay. In contrast quantitation of RSV by ELISA was not affected by palivizumab treatment. This finding is consistent with results that were obtained in preliminary studies of RSV- containing media treated with monoclonal antibody, where we found that the ELISA measured virus whether antibody-bound or not. The inflammatory indices were not correlated with RSV concentration measured by ELISA or plaque assay. Conclusions. We conclude that this quantitative ELISA is a potentially useful tool for measurement of RSV concentration in respiratory secretions that may help elucidate the pathophysiology of acute RSV infection. Specific antiviral strategies for the treatment of RSV disease could be evaluated by this method.

KW - Enzyme-linked immunosorbent assay

KW - Respiratory syncytial virus

KW - Tracheal secretions

UR - http://www.scopus.com/inward/record.url?scp=0033957265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033957265&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 1

EP - 7

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 1

ER -